Passage Bio, Inc. (PASG)
NASDAQ: PASG · Real-Time Price · USD
12.45
-0.13 (-1.03%)
Jan 26, 2026, 4:00 PM EST - Market closed
Passage Bio Market Cap
Passage Bio has a market cap or net worth of $39.57 million as of January 27, 2026. Its market cap has decreased by -8.47% in one year.
Market Cap
39.57M
Enterprise Value
11.14M
1-Year Change
-8.47%
Ranking
Category
Stock Price
$12.45
Market Cap Chart
Since February 28, 2020, Passage Bio's market cap has decreased from $956.75M to $39.57M, a decrease of -95.86%. That is a compound annual growth rate of -41.68%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 23, 2026 | 39.99M | 6.61% |
| Dec 31, 2025 | 37.51M | 7.08% |
| Dec 31, 2024 | 35.03M | -36.74% |
| Dec 29, 2023 | 55.37M | -26.45% |
| Dec 30, 2022 | 75.28M | -78.09% |
| Dec 31, 2021 | 343.58M | -70.49% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Feb 28, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Estrella Immunopharma | 42.45M |
| NextCure | 41.79M |
| Galecto | 41.15M |
| Actinium Pharmaceuticals | 40.55M |
| TuHURA Biosciences | 40.54M |
| OnKure Therapeutics | 39.70M |
| Exicure | 39.26M |
| Lantern Pharma | 38.70M |